Riskpilot← Back to searchSign inGet full accessEYEFIVE AS
ASActiveOrg 923865578Høvleriveien 1A, 3114 TønsbergMedical specialists activities · NACE 8622Est. 20192 employees
Revenue 2024
NOK 10,7M
+85% vs 2023
EBITDA margin
17.5%
+79% vs 2023
Equity ratio
43.7%
Financial strength
Net profit 2024
NOK 670K
+4% vs 2023
| Revenue | NOK 10,7M | +85% |
| EBITDA | NOK 1,9M | +79% |
| Net profit | NOK 670K | +4% |
| Total assets | NOK 7M | +103% |
| Equity | NOK 3,1M | +28% |
| Employees | 2 | — |
Legal name
EYEFIVE AS
Org number
923865578
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
21. november 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legedrift. Spesialist øyelege, utleie øyelege og alt som faller naturlig inn under dette. Deltakelse i andre selskaper.
Address
Høvleriveien 1A, 3114 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 3 326 | 3 781 | 4 971 | 5 793 | 10 733 |
| Staff expenses | −0 | −1 029 | −1 837 | −1 998 | −3 933 | −2 913 |
| EBITDA | −6 | 1 932 | 8 | 1 446 | 1 052 | 1 880 |
| Depreciation & amort. | −0 | −6 | −75 | −171 | −208 | −1 020 |
| EBIT | −6 | 1 926 | −67 | 1 275 | 844 | 860 |
| Net financials | 0 | −0 | −0 | 0 | −4 | 2 |
| Profit before tax | −6 | 1 926 | −67 | 1 275 | 841 | 862 |
| Tax | −1 | 424 | −5 | 277 | 196 | 192 |
| Net profit | −4 | 1 502 | −62 | 998 | 645 | 670 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 26 | 2 190 | 1 622 | 2 356 | 3 477 | 7 050 |
| Equity | 26 | 1 328 | 765 | 1 764 | 2 409 | 3 080 |
| Long-term debt | 0 | 5 | 0 | 16 | 34 | 1 277 |
| Short-term debt | 0 | 857 | 856 | 576 | 1 033 | 2 693 |
| Total debt | 0 | 862 | 856 | 592 | 1 067 | 3 970 |
EBITDA margin
17.5%
This company
15.8%
Market median
+11% vs market
20192024
Equity ratio
43.7%
This company
38.2%
Market median
+14% vs market
20192024
Return on equity
21.8%
This company
18.4%
Market median
+18% vs market
20192024
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20192024
Asset turnover
1.52×
This company
1.12×
Market median
+36% vs market
20192024
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VR Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
EYEFIVE AS 
TØNSBERG ØYELEGESENTER ASBoard members of EYEFIVE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vinita Rangroo Thrane | Chief Executive Officer | 0 companies |
| Alexander Stanley Thrane | Board of Directors | 0 companies |